Products

Ambit’s growing data products portfolio empowers our clients to understand and engage rare disease markets more rapidly, efficiently, & effectively.

Ambit is much more than a professional services firm.

Our Product Development teams are at the forefront of using data and technology to develop transformative biopharma solutions for rare and specialty diseases at scale. Our passion lies in the intersection of strategy, data analytics, and cutting-edge technology, and we collaborate closely with our esteemed clients to tackle intricate challenges across pre-commercial and commercial landscapes. 

Our suite of interconnected products and services is underpinned by the latest technology and data expertise. Each of our offerings is testament to decades of experience in consulting, biopharma, commercialization, medical innovation, digital transformation, and data science.

Our suite of interconnected products and services is underpinned by the latest technology and data expertise. Each of our offerings is testament to decades of experience in consulting, biopharma, commercialization, medical innovation, digital transformation, and data science.

Ambit Bit@2x

Looking to get in touch?

Reach out today and we will get back to you shortly.

Play Video about Ambit is a tech enabled solutions company.

Our initial suite of data products focuses on the challenge of finding appropriate specialty and rare disease patients for clinical trials and approved therapies – one of the most common sources of friction for our clients.  

Ambit’s patient finding products engage both patients and HCPs through a combination of advanced data analytics, omnichannel marketing and direct outreach through our team of Ambit Guides.  

Dynamic LeadGen

AI/ML modeling and rules-based triggers providing timely, high-quality HCP leads to the field force, with omni-channel engagement extending coverage to target HCPs not accessible by the field teams.

Patient Activate

End-to-end patient finding for biopharma companies struggling to identify specialty and rare disease patients for commercial or pre-commercial purposes.

Join our Mailing list!

Get all latest news and updates.